To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
AbCellera, a Vancouver, British Columbia-based developer of therapeutic antibodies, has closed its IPO on the NASDAQ at a price of US$20 per share, including the greenshoe option.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Copyright PEI Media
Not for publication, email or dissemination